These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 15128422)
1. Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases. Sohn SK; Kim DH; Kim JG; Sung WJ; Baek JH; Lee NY; Won DI; Suh JS; Lee KS; Lee KB Eur J Haematol; 2004 Jun; 72(6):430-6. PubMed ID: 15128422 [TBL] [Abstract][Full Text] [Related]
2. T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome. Montero A; Savani BN; Shenoy A; Read EJ; Carter CS; Leitman SF; Mielke S; Rezvani K; Childs R; Barrett AJ Biol Blood Marrow Transplant; 2006 Dec; 12(12):1318-25. PubMed ID: 17162214 [TBL] [Abstract][Full Text] [Related]
4. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation. Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT. Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337 [TBL] [Abstract][Full Text] [Related]
6. Transplantation with higher dose of natural killer cells associated with better outcomes in terms of non-relapse mortality and infectious events after allogeneic peripheral blood stem cell transplantation from HLA-matched sibling donors. Kim DH; Sohn SK; Lee NY; Baek JH; Kim JG; Won DI; Suh JS; Lee KB; Shin IH Eur J Haematol; 2005 Oct; 75(4):299-308. PubMed ID: 16146536 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation. Cutler C; Kim HT; Hochberg E; Ho V; Alyea E; Lee SJ; Fisher DC; Miklos D; Levin J; Sonis S; Soiffer RJ; Antin JH Biol Blood Marrow Transplant; 2004 May; 10(5):328-36. PubMed ID: 15111932 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic peripheral blood stem cell transplantations in children--a single center experience. Sufliarska S; Horáková J; Bodová I; Martinka J; Hrubisko M; Kovács L; Jancovicová K; Lukác J Neoplasma; 2004; 51(2):110-6. PubMed ID: 15190420 [TBL] [Abstract][Full Text] [Related]
10. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507 [TBL] [Abstract][Full Text] [Related]
11. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold? Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837 [TBL] [Abstract][Full Text] [Related]
12. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission. Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic peripheral blood stem cell transplantation (PBSCT) from HLA-identical sibling donors in children with hematological diseases: a single center pilot study. Benito AI; Gonzalez-Vicent M; Garcia F; Balas A; Quintero V; Madero L; Vicario JL; Diaz MA Bone Marrow Transplant; 2001 Sep; 28(6):537-43. PubMed ID: 11607765 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study. Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469 [TBL] [Abstract][Full Text] [Related]
15. One-year cyclosporine prophylaxis reduces the risk of developing extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation. Mengarelli A; Iori AP; Romano A; Cerretti R; Cerilli L; De Propris MS; Fenu S; Moleti ML; De Felice L; Girelli G; Arcese W Haematologica; 2003 Mar; 88(3):315-23. PubMed ID: 12651271 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies. Yamasaki S; Ohno Y; Taniguchi S; Yoshida T; Hayashi S; Ogawa H; Shimazaki C; Takahashi S; Kasai M; Wake A; Nishimura M; Tokunaga K; Gondo H; Takaue Y; Harada M; Mineishi S; Bone Marrow Transplant; 2004 Feb; 33(3):279-89. PubMed ID: 14647250 [TBL] [Abstract][Full Text] [Related]
17. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation]. Sawada H; Wake A; Yamasaki Y; Izumi Y Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350 [TBL] [Abstract][Full Text] [Related]
18. [Allogeneic peripheral blood stem cell transplantation for high-risk leukemia]. Huang X; Wang F; Guo N Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1348-51. PubMed ID: 11930625 [TBL] [Abstract][Full Text] [Related]
19. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation. Lickliter JD; McGlave PB; DeFor TE; Miller JS; Ramsay NK; Verfaillie CM; Burns LJ; Wagner JE; Eastlund T; Dusenbery K; Weisdorf DJ Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652 [TBL] [Abstract][Full Text] [Related]
20. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]